Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
Más filtros

Tipo del documento
Intervalo de año de publicación
1.
J Infect Chemother ; 23(11): 778-781, 2017 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-28527648

RESUMEN

A 23-year-old Japanese woman presented with abdominal distention following fever, diarrhea, and abdominal pain during a stay in Taiwan. Serology for the detection of amebic-antibodies and stool microscopic examination were both negative. A computed tomography scan showed a 13 cm diameter abscess spreading from the lower abdominal wall to the pelvic retroperitoneal space. Needle aspiration of the abscess was done under computed tomography guidance, and microscopy of the aspirated fluid revealed trophozoites of Entamoeba. The patient was diagnosed as amebiasis with negative serologic markers that caused intra-abdominal abscess. Intravenous metronidazole treatment for two weeks did not result in any improvement of the abscess. After irrigation and drainage of the abscess, her symptoms resolved. This case report highlights that amebiasis should be considered when indicated by patient history, including travelers returning from endemic areas, and that further evaluation is necessary for diagnosis, even if the serology and stool test are negative.


Asunto(s)
Absceso Abdominal/parasitología , Dolor Abdominal/parasitología , Amebicidas/uso terapéutico , Entamebiasis/complicaciones , Fiebre/parasitología , Absceso Abdominal/sangre , Absceso Abdominal/patología , Absceso Abdominal/terapia , Dolor Abdominal/sangre , Dolor Abdominal/patología , Dolor Abdominal/terapia , Antibacterianos/uso terapéutico , Biomarcadores/sangre , Biopsia con Aguja Fina/métodos , Proteína C-Reactiva/análisis , Colonoscopía , Drenaje , Entamoeba histolytica/inmunología , Entamoeba histolytica/aislamiento & purificación , Entamebiasis/sangre , Entamebiasis/parasitología , Entamebiasis/terapia , Femenino , Fiebre/sangre , Fiebre/patología , Fiebre/terapia , Humanos , Imagen por Resonancia Magnética , Pruebas Serológicas , Taiwán , Irrigación Terapéutica , Tomografía Computarizada por Rayos X/métodos , Trofozoítos/aislamiento & purificación , Adulto Joven
2.
Mol Microbiol ; 98(2): 208-17, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26173474

RESUMEN

The development of molecular microbiology has made it possible for us to deepen our understanding of the pathogenesis of amebiasis. Research using the trophozoite form of Entamoeba histolytica has clearly shown us the importance of the interface between the parasite and host cells in vitro. Immuno-pathogenesis after excystation was similarly well advanced by the use of a novel murine model of amebic colitis. However, it is still challenging to apply these findings to clinical and epidemiological settings. This is mainly because of the lack of a complete infection animal model of amebiasis by oral-fecal infection. Moreover, in vitro experiments have predominantly been performed using the same axenic cultured strain HM-1: IMSS isolated about 50 years ago, whereas highly diverse strains are prevalent all over the world. Translational research informed by clinical observations has the greatest potential for the development of effective interventions. Here, we highlight discoveries of the experiments designed from cohort observation and discuss remaining problems to be solved.


Asunto(s)
Investigación Biomédica , Entamoeba histolytica/patogenicidad , Entamebiasis , Animales , Modelos Animales de Enfermedad , Entamebiasis/parasitología , Entamebiasis/prevención & control , Entamebiasis/terapia , Interacciones Huésped-Parásitos/genética , Humanos , Ratones , Biología Molecular/métodos , Virulencia
3.
Trop Gastroenterol ; 36(4): 251-5, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-27509703

RESUMEN

BACKGROUND: Amebic liver abscess (ALA) is a common and serious problem in our country. There are only a few controlled trials on the efficacy and advantages of combination therapy with percutaneous needle aspiration and pharmacotherapy, over pharmacotherapy alone for amebic liver abscess. MATERIAL AND METHODS: This study was conducted to compare the efficacy of two different treatment modalities i.e. drug treatment alone vs. drug treatment and aspiration of abscess cavity in patients with small (up to 5 cm) and large (5 cm to 10 cm) size ALA. This is one of the largest single center, prospective, randomized studies comparing the efficacy of aspiration in ALA. RESULTS: (i) Mean body temperature, liver tenderness, total leukocyte count (TLC), serum alanine aminotransferase (ALT) and liver span were significantly decreased in the aspiration group on days 8 and 15 as compared to non-aspiration group especially in large abscess (5 cm to 10 cm). (ii) Abscess cavity maximum diameter decreased significantly in aspiration group on days 8 and 15, and 1 month & 3 months in large abscess (5cm to 10 cm). CONCLUSIONS: (i) Needle aspiration along with metronidazole hastens clinical improvement especially in large (5 cm up to 10 cm) cavities in patients with ALA. (ii) Aspiration is safe and no major complications occurred. (iii) Hence, combination therapy should be the first choice especially in large ALA (5 cm to 10 cm).


Asunto(s)
Antiprotozoarios/uso terapéutico , Entamebiasis/terapia , Absceso Hepático Amebiano/terapia , Metronidazol/uso terapéutico , Paracentesis/métodos , Alanina Transaminasa/sangre , Terapia Combinada , Entamebiasis/sangre , Entamebiasis/patología , Fiebre , Humanos , India , Recuento de Leucocitos , Hígado/patología , Absceso Hepático Amebiano/sangre , Absceso Hepático Amebiano/patología , Tamaño de los Órganos , Resultado del Tratamiento
4.
Semin Cutan Med Surg ; 33(3): 133-5, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25577853

RESUMEN

In today's world, many people can travel easily and quickly around the globe. Most travel travel-related illnesses include fever, diarrhea, and skin disease, which are relatively uncommon in returning travelers. We review four of the most common emerging infestations and skin infections in the Americas, which are important to the clinical dermatologist, focusing on the clinical presentation and treatment of cutaneous larva migrans, gnathostomiasis, cutaneous amebiasis, and trombiculiasis.


Asunto(s)
Entamebiasis/diagnóstico , Gnathostomiasis/diagnóstico , Larva Migrans/diagnóstico , Viaje , Trombiculiasis/diagnóstico , Clima Tropical , Diagnóstico Diferencial , Entamebiasis/parasitología , Entamebiasis/terapia , Entamebiasis/transmisión , Gnathostomiasis/parasitología , Gnathostomiasis/terapia , Gnathostomiasis/transmisión , Humanos , Larva Migrans/parasitología , Larva Migrans/terapia , Larva Migrans/transmisión , Trombiculiasis/parasitología , Trombiculiasis/terapia , Trombiculiasis/transmisión
5.
ScientificWorldJournal ; 2014: 364264, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24605052

RESUMEN

Entamoeba histolytica is a protozoan parasite that presents a risk to the health of millions of people worldwide. Due to the existence of different clinical forms caused by the parasite and also different virulence levels presented by one strain, one would expect differences in the profile of gene transcripts between virulent and nonvirulent cultures. In this study we used the differential display to select gene segments related to invasiveness of amoeba. One Brazilian strain of E. histolytica in two conditions, able or not to cause lesions in experimental animals, was used. RNA from this strain, was used to study the differential expression of genes. 29 specific gene fragments differentially expressed in the virulent strain were selected. By real-time PCR, six of these genes had confirmed their differential expression in the virulent culture. These genes may have important roles in triggering invasive amoebiasis and may be related to adaptation of trophozoites to difficulties encountered during colonization of the intestinal epithelium and liver tissue. Future studies with these genes may elucidate its actual role in tissue invasion by E. histolytica generating new pathways for diagnosis and treatment of amoebiasis.


Asunto(s)
Entamoeba histolytica/metabolismo , Entamebiasis/metabolismo , Regulación de la Expresión Génica , ARN Protozoario/biosíntesis , Animales , Entamoeba histolytica/genética , Entamoeba histolytica/patogenicidad , Entamebiasis/genética , Entamebiasis/terapia , Humanos , Ratones , ARN Protozoario/genética , Ratas
6.
Adv Exp Med Biol ; 712: 62-83, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21660659

RESUMEN

Cysteine proteases of the protozoan parasite Entamoeba histolytica are key virulence factors involved in overcoming host defences. These proteases are cathepsin-like enzymes with a cathepsin-L like structure, but cathepsin-B substrate specificity. In the host intestine, amoeba cysteine proteases cleave colonic mucins and degrade secretory immunoglobulin (Ig) A and IgG rendering them ineffective. They also act on epithelial tight junctions and degrade the extracellular matrix to promote Cell death. They are involved in the destruction of red blood cells and the evasion of neutrophils and macrophages and they activate pro-inflammatory cytokines IL- 1ß and IL-18. In short, amoeba cysteine proteases manipulate and destroy host defences to facilitate nutrient acquisition, parasite colonization and/or invasion. Strategies to inhibit the activity of amoeba cysteine proteases could contribute significantly to host protection against E. histolytica.


Asunto(s)
Catepsinas/metabolismo , Entamoeba histolytica/enzimología , Tracto Gastrointestinal/parasitología , Interacciones Huésped-Parásitos , Catepsinas/química , Entamoeba histolytica/patogenicidad , Entamebiasis/parasitología , Entamebiasis/terapia , Humanos
7.
Curr Gastroenterol Rep ; 9(5): 429-33, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17991346

RESUMEN

Amebiasis, caused by the protozoan parasite Entamoeba histolytica, affects more than 50 million people worldwide, with over 100,000 deaths annually. The majority of cases are asymptomatic; however, significant morbidity and mortality are associated with illness in the remaining 10% of cases. Recent advances in the understanding of the mechanism of infection by E. histolytica, the role of the innate immune system, and the role of genetic disposition to infection will allow the development of novel detection and treatment methods. The disease mechanisms, clinical findings, therapeutic strategies, and important developments regarding amebiasis are discussed here.


Asunto(s)
Disentería Amebiana/diagnóstico , Disentería Amebiana/terapia , Entamoeba histolytica/aislamiento & purificación , Entamebiasis/diagnóstico , Tinidazol/uso terapéutico , Adolescente , Adulto , Distribución por Edad , Animales , Bangladesh/epidemiología , Niño , Preescolar , Países en Desarrollo , Disentería Amebiana/epidemiología , Entamoeba histolytica/efectos de los fármacos , Entamebiasis/epidemiología , Entamebiasis/prevención & control , Entamebiasis/terapia , Humanos , Incidencia , Masculino , Pronóstico , Vacunas Antiprotozoos/administración & dosificación , Medición de Riesgo , Índice de Severidad de la Enfermedad , Distribución por Sexo
8.
World J Gastroenterol ; 13(42): 5659-61, 2007 Nov 14.
Artículo en Inglés | MEDLINE | ID: mdl-17948943

RESUMEN

A 54-year-old man presented with rectal pain and bleeding secondary to ulcerated, necrotic rectal and cecal masses that resembled colorectal carcinoma upon colonoscopy. These masses were later determined to be benign amebomas caused by invasive Entamoeba histolytica, which regressed completely with medical therapy. In Western countries, the occurrence of invasive protozoan infection with formation of amebomas is very rare and can mistakenly masquerade as a neoplasm. Not surprisingly, there have been very few cases reported of this clinical entity within the United States. Moreover, we report a patient that had an extremely rare occurrence of two synchronous lesions, one involving the rectum and the other situated in the cecum. We review the current literature on the pathogenesis of invasive E. histolytica infection and ameboma formation, as well as management of this rare disease entity at a western medical center.


Asunto(s)
Entamoeba histolytica , Entamebiasis/diagnóstico , Enfermedades del Recto/diagnóstico , Animales , Neoplasias Colorrectales/diagnóstico , Diagnóstico Diferencial , Entamebiasis/patología , Entamebiasis/terapia , Humanos , Masculino , Persona de Mediana Edad
9.
Chirurgia (Bucur) ; 101(5): 539-42, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17278650

RESUMEN

Digestive amoebiasis with his invasive form is an unusual pathology encountered in the temperate zone. This could lead to a life threatening complication: systemic amoebiasis. A 55-year-old male was treated successfully of systemic amoebiasis in a third referral hospital. The diagnosis was established based on epidemiology data and microscopical identification of trophozoites of Entamoeba histolytica. The amoebicidal, antibiotic and supportive treatments was firstly administrated. The clinical picture of intestinal amoebiasis raised from dysenteric syndrome to necrotizing enteritis. The bowel perforation with localized peritonitis was followed by chronic enteric fistula. Amoebic liver abscess, as the most frequent extraintestinal complication, was concomitantly diagnosed and treated. Urinary amoebiasis was considered as complication in the context of systemic dissemination: any other location could become a site of an amoebic abscess. Multidisciplinary approach was the successful key in the management of the patient, including antiparasitic therapy and antibiotic prophylaxis, intensive care and multiple surgical approaches. The diagnosis of digestive amoebiasis and systemic complication may be delayed in nonendemic areas, leading to advanced and complicated stages of the disease. The surgical approach is most efficiently to treat a large liver amoebic abscess and intraperitoneal collections.


Asunto(s)
Entamebiasis/terapia , Ileítis/terapia , Fístula Intestinal/terapia , Absceso Hepático Amebiano/terapia , Amebicidas/uso terapéutico , Animales , Antibacterianos/uso terapéutico , Antifúngicos/uso terapéutico , Antiprotozoarios/uso terapéutico , Quimioterapia Combinada , Entamoeba histolytica/aislamiento & purificación , Entamebiasis/diagnóstico , Entamebiasis/parasitología , Humanos , Ileítis/diagnóstico , Ileítis/parasitología , Fístula Intestinal/diagnóstico , Fístula Intestinal/parasitología , Absceso Hepático Amebiano/diagnóstico , Absceso Hepático Amebiano/parasitología , Masculino , Persona de Mediana Edad , Reoperación , Succión , Resultado del Tratamiento
11.
Immunobiology ; 176(4-5): 341-53, 1988 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-2899056

RESUMEN

The effect of murine interferon gamma (IFN-gamma) on macrophage activation for amoebicidal activity was examined. Peritoneal macrophages were harvested from C57BL/6 mice and preincubated with IFN-gamma and/or lipopolysaccharide (LPS). In vitro amoebicidal activity of these macrophages was determined by trypan blue exclusion test against a virulent strain of E. histolytica (IP:0682:1). It was found that in vitro amoebicidal activity was evident in macrophage monolayers treated with both IFN-gamma and LPS. Macrophages treated with IFN-gamma alone did not develop cytotoxic activity unless they were exposed to LPS as a second triggering signal. The ability of IFN-gamma to prime macrophages to respond to trigger signals of LPS and develop cytotoxicity increased with time of incubation, the highest response being observed after 24 h. There was a dose-dependent relationship between the concentrations of both IFN-gamma and LPS used to activate macrophages and the number of dead trophozoites. These data suggest that macrophages are important in host defense against amoebiasis.


Asunto(s)
Amebiasis/terapia , Entamoeba histolytica/inmunología , Entamebiasis/terapia , Inmunoterapia , Interferón gamma/uso terapéutico , Activación de Macrófagos , Macrófagos/inmunología , Proteínas Recombinantes/uso terapéutico , Animales , Células Cultivadas , Lipopolisacáridos/inmunología , Masculino , Ratones , Ratones Endogámicos C57BL
12.
Arch Surg ; 113(3): 322-5, 1978 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-205190

RESUMEN

We present two successfully treated cases of amebic peritonitis. Acute peritonitis secondary to intra-abdominal rupture of an amebic liver abscess is an infrequent but serious complication of invasive amebiasis. Its diagnosis should be considered in anyone with a suspected liver abscess, jaundice, or diarrhea in whom peritonitis develops. This diagnosis should be further suggested in the United States if the patient is a male and is of Mexican origin in areas where this racial group constitutes the majority of cases of amebic disease. Use of radioisotope liver scans and the demonstration of serum precipitins to Endamoeba histolytica may provide rapid evidence of invasive disease, although surgical intervention is often necessary to make a specific diagnosis. Emetine hydrochloride alone or followed by metronidazole combined with surgical drainage is the current treatment for amebic peritonitis.


Asunto(s)
Amebiasis , Entamebiasis , Absceso Hepático Amebiano/complicaciones , Peritonitis/etiología , Adulto , Entamoeba histolytica , Entamebiasis/diagnóstico , Entamebiasis/terapia , Humanos , Masculino , México/etnología , Peritonitis/diagnóstico , Peritonitis/terapia , Rotura Espontánea , Texas
13.
Am J Trop Med Hyg ; 51(2): 180-2, 1994 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7915500

RESUMEN

We successfully treated a serious case of Entamoeba histolytica infection showing brain abscess, meningitis, and liver abscess by oral administration of metronidazole, intramuscular injection of dehydroemetine, and drainage of the brain abscess. The diagnosis of amebic brain abscess was based on a combination of clinical symptoms and signs, computed tomography and magnetic resonance imaging findings, a positive serologic test result for E. histolytica, a dramatic response to anti-amebic drugs after an ineffective therapeutic history with antibacterial drugs, and application of the polymerase chain reaction method.


Asunto(s)
Absceso Encefálico/parasitología , Entamoeba histolytica/aislamiento & purificación , Entamebiasis/diagnóstico , Administración Oral , Animales , Anticuerpos Antiprotozoarios/sangre , Absceso Encefálico/diagnóstico , Absceso Encefálico/terapia , ADN Protozoario/análisis , Drenaje , Emetina/administración & dosificación , Emetina/uso terapéutico , Entamoeba histolytica/genética , Entamoeba histolytica/inmunología , Entamebiasis/terapia , Ensayo de Inmunoadsorción Enzimática , Humanos , Inyecciones Intramusculares , Intubación Gastrointestinal , Absceso Hepático Amebiano/complicaciones , Imagen por Resonancia Magnética , Masculino , Meningitis/complicaciones , Meningitis/parasitología , Metronidazol/administración & dosificación , Metronidazol/uso terapéutico , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Tomografía Computarizada por Rayos X
14.
Clin Chest Med ; 23(2): 479-92, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12092041

RESUMEN

Pleuropulmonary amebiasis is the common and pericardial amebiasis the rare form of thoracic amebiasis. Low socioeconomic conditions, malnutrition, chronic alcoholism, and ASD with left to right shunt are contributing factors to the development of pulmonary amebiasis. Although no age is exempt, it commonly occurs in patients aged 20 to 40 years, with an adult male to female ratio of 10:1. Children rarely develop thoracic amebiasis: when it does occur there is an equal sex distribution. The infection usually spreads to the lungs by extension of an amebic liver abscess. Infection may pass to the thorax directly from the primary intestinal lesion through hematogenous spread, however. Lymphatic spread is one possible route. Inhalation of dust containing cysts and aspiration of cysts or trophozoites of E histolytica in the lungs are some other hypothetical routes. The lung is the second most common extraintestinal site of amebic involvement after the liver. Usually the lower lobe, and sometimes the middle lobe of the right lung, are affected, but it may affect any lobe of the lungs. The patient develops fever and right upper quadrant pain that is referred to the tip of the right shoulder or in between the scapula. Hemophtysis is common. The diagnosis of thoracic amebiasis is suggested by the combination of an elevated hemidiaphragm (usually right), hepatomegaly, pleural effusion, and involvement of the right lung base in the form of haziness and obliteration of costophrenic and costodiaphragmatic angles. Infection is usually extended to the thorax by perforation of a hepatic abscess through the diaphragm and across an obliterated pleural space, producing pulmonary consolidation, abscesses, or broncho-hepatic fistula. Empyema develops when a liver abscess ruptures into the pleural space. Rarely, a posterior amebic liver abscess can burst into the inferior vena cava and develop an embolism of the inferior vena cava and thromboembolic disease of the lungs with congestive cardiac failure or corpulmonale. Diagnosis by finding E histolytica in stool specimens is of limited value. In a limited number of cases amebae might be found in aspirated pus or expectorated sputum. "Anchovy sauce-like" pus or sputum may be found. Presence of bile in sputum indicates that the pus is of liver origin. Serological tests are of immense value in diagnosis. Liver enzymes are usually normal and neutrophilic leucocytosis may or may not be found. ESR is invariably elevated. Anti-amebic antibodies can be detected by ELISA, IFAT, and IHA. Amebic antigen can be detected from serum and pus by ELISA. Detection of Entamoeba DNA in pus or sputum may be a sensitive and specific method. Pleuropulmonary amebiasis is easily confused with other illnesses and is treated as pulmonary TB, bacterial lung abscesses, and carcinoma of the lung. A single drug regimen with metronidazole with supportive therapy usually cures patients without residual anomalies. Aspiration of pus from empyema thoracis may be needed for confirmation and therapeutic purposes. The pericardium is usually involved by direct extension from the amebic abscess of the left lobe of the liver, sometimes from the right lobe of the liver, and rarely from the lungs or pleura. An initial accumulation of serous fluid due to reactive pericarditis followed by intrapericardial rupture may develop either (1) acute onset of severe symptoms with chest pain, dyspnea, and cardiac tamponade, shock, and death, or (2) progressive effusion with thoracic cage pain, progressive dyspnea, and fever. Chest radiograph, ultrasound examination, and CT scan usually confirm the presence of a liver abscess in continuity with the pericardium and fluid within the pericardial sac with or without the fistulous tract. Echocardiography may demonstrate fluid in the pericardial cavity. Patients should be cared for in the ICU and ambecides should be started without delay. Pericardiocentesis usually confirms the diagnosis and improves the general condition of the patient. Aspiration of the accumulated fluid should be performed urgently in cardiac tamponade; repeated aspiration may be needed. Surgical drainage should be done if needed. Acanthamoeba, a free-living ameba, may also infect the lungs in the form of pulmonary nodular infiltration and pulmonary edema in association with amebic meningoencephalitis in immunocompromised patients. It usually spreads to the meninges of the brain by way of the blood from its primary lesion in the lung or skin. Early diagnosis and institution of treatment may be life saving for these patients. A literature review shows that HIV/AIDS patients are not prone to infection with E histolytica. It is now clear that there are an increasing number of HIV-seropositive patients among amebic liver abscess patients, however, which suggests that although the incidence of intestinal infection is not high among HIV-seropositive or AIDS patients they are more susceptible to an invasive form of the disease.


Asunto(s)
Entamebiasis , Enfermedades Pulmonares Parasitarias , Animales , Entamoeba histolytica/patogenicidad , Entamebiasis/diagnóstico , Entamebiasis/epidemiología , Entamebiasis/parasitología , Entamebiasis/terapia , Humanos , Enfermedades Pulmonares Parasitarias/diagnóstico , Enfermedades Pulmonares Parasitarias/epidemiología , Enfermedades Pulmonares Parasitarias/parasitología , Enfermedades Pulmonares Parasitarias/terapia
15.
Jpn J Infect Dis ; 53(6): 229-37, 2000 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11227020

RESUMEN

Amebiasis is epidemic in two major populations in Japan: male homosexuals and institutionalized people. Currently available diagnostic, chemotherapeutic, and prophylactic measures and their problems are discussed. Recent advances in basic research on amebiasis are also described with new findings of unique metabolisms and intracellular structures and organization. Discoveries and analyses of the unique features presented by this parasitic protist help in our elucidation of the pathogenic mechanisms of the parasite and may eventually lead to the development of new drugs and vaccines against amebiasis.


Asunto(s)
Entamoeba histolytica , Entamebiasis/epidemiología , Animales , Antiprotozoarios/uso terapéutico , Enfermedades Endémicas , Entamoeba histolytica/crecimiento & desarrollo , Entamoeba histolytica/patogenicidad , Entamebiasis/parasitología , Entamebiasis/terapia , Humanos , Japón/epidemiología , Masculino , Microscopía Electrónica , Vacunas Antiprotozoos/inmunología
16.
J Assoc Physicians India ; 52: 251-2, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15636321

RESUMEN

A patient of cerebral amoebiasis due to Entamoeba histolytica with no evidence of disease elsewhere is described. He made a complete recovery after surgical excision of the abscess along with metronidazole therapy.


Asunto(s)
Absceso Encefálico/parasitología , Entamoeba histolytica/aislamiento & purificación , Entamebiasis/complicaciones , Animales , Absceso Encefálico/diagnóstico , Absceso Encefálico/terapia , Niño , Craneotomía , Diagnóstico Diferencial , Entamebiasis/diagnóstico , Entamebiasis/terapia , Humanos , Masculino , Metronidazol/uso terapéutico
18.
Semin Pediatr Surg ; 21(2): 142-50, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-22475120

RESUMEN

Parasitic infestation is common in developing countries especially in Africa. Children are often more vulnerable to these infections. Many health problems result from these infestations, including malnutrition, iron-deficiency anemia, surgical morbidities, and even impaired cognitive function and educational achievement. Surgical intervention may be needed to treat serious complications caused by some of these parasites. Amoebic colitis and liver abscess caused by protozoan infections; intestinal obstruction, biliary infestation with cholangitis and liver abscess, and pancreatitis caused by Ascaris lumbricoides; biliary obstruction caused by Faschiola; hepatic and pulmonary hydatid cysts caused by Echinococcus granulosus and multilocularis are examples. Expenditure of medical care of affected children may cause a great burden on many African governments, which are already suffering from economic instability. The clinical presentation, investigation, and management of some parasitic infestations of surgical relevance in African children are discussed in this article.


Asunto(s)
Enfermedades Parasitarias/cirugía , África/epidemiología , Ascariasis/diagnóstico , Ascariasis/epidemiología , Ascariasis/cirugía , Ascariasis/terapia , Niño , Dracunculiasis/diagnóstico , Dracunculiasis/epidemiología , Dracunculiasis/cirugía , Dracunculiasis/terapia , Equinococosis/diagnóstico , Equinococosis/epidemiología , Equinococosis/cirugía , Equinococosis/terapia , Entamebiasis/diagnóstico , Entamebiasis/epidemiología , Entamebiasis/cirugía , Entamebiasis/terapia , Enterobiasis/diagnóstico , Enterobiasis/epidemiología , Enterobiasis/cirugía , Helmintiasis/epidemiología , Helmintiasis/cirugía , Humanos , Miasis/diagnóstico , Miasis/epidemiología , Miasis/cirugía , Miasis/terapia , Enfermedades Parasitarias/diagnóstico , Enfermedades Parasitarias/epidemiología , Enfermedades Parasitarias/terapia , Esquistosomiasis/diagnóstico , Esquistosomiasis/epidemiología , Esquistosomiasis/cirugía , Esquistosomiasis/terapia
20.
Wkly Epidemiol Rec ; 72(14): 97-9, 1997 Apr 04.
Artículo en Inglés, Francés | MEDLINE | ID: mdl-9100475
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA